Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotection by post‐stroke administration of an oral formulation of angiotensin‐(1–7) in ischaemic stroke
Douglas M. Bennion, Chad H. Jones, Lauren L. Donnangelo, et al.
Experimental Physiology (2018) Vol. 103, Iss. 6, pp. 916-923
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Counter-regulatory renin–angiotensin system in cardiovascular disease
María Paz Ocaranza, Jaime A. Riquelme, Lorena Garcı́a, et al.
Nature Reviews Cardiology (2019) Vol. 17, Iss. 2, pp. 116-129
Open Access | Times Cited: 483
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models
Natália Alenina, Michael Bäder
Neurochemical Research (2018) Vol. 44, Iss. 6, pp. 1323-1329
Open Access | Times Cited: 132
Angiotensin-(1-7) Provides Potent Long-Term Neurorepair/Neuroregeneration in a Rodent White Matter Stroke Model: Nonarteritic Ischemic Optic Neuropathy (rNAION)
Kwang Min Woo, Yan Guo, Zara Mehrabian, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 289-289
Open Access
The depressor axis of the renin–angiotensin system and brain disorders: a translational approach
Mariela M. Gironacci, Augusto Vicario, Gustavo H. Cerezo, et al.
Clinical Science (2018) Vol. 132, Iss. 10, pp. 1021-1038
Open Access | Times Cited: 53
Recent Advances in the Therapeutic and Diagnostic Use of Liposomes and Carbon Nanomaterials in Ischemic Stroke
Lorena F. Fernandes, Gisele Eva Bruch, André Ricardo Massensini, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 53
Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”
Christopher R. Apostol, Meredith Hay, Robin Polt
Peptides (2020) Vol. 131, pp. 170369-170369
Open Access | Times Cited: 43
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
Fabio Panariello, Lorenzo Cellini, Maurizio Speciani, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 42
Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
Upinder Kaur, Kumudini Acharya, Ritwick Mondal, et al.
European Journal of Pharmacology (2020) Vol. 887, pp. 173545-173545
Open Access | Times Cited: 35
Targeting inflammation and redox aberrations by perindopril attenuates methotrexate-induced intestinal injury in rats: Role of TLR4/NF-κB and c-Fos/c-Jun pro-inflammatory pathways and PPAR-γ/SIRT1 cytoprotective signals
Ahmed M. Sayed, Maha M. Abdel‐Fattah, Hany H. Arab, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109732-109732
Closed Access | Times Cited: 27
Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats
Maha M. Abdel‐Fattah, Basim Anwar Shehata Messiha, Ahmed M. Mansour
Naunyn-Schmiedeberg s Archives of Pharmacology (2018) Vol. 391, Iss. 9, pp. 1003-1020
Closed Access | Times Cited: 33
Xanthenone, ACE2 activator, counteracted gentamicin-induced nephrotoxicity in rats: Impact on oxidative stress and ACE2/Ang-(1–7) signaling
Maha M. Abdel‐Fattah, Abdel Nasser A.M. Elgendy, Wafaa R. Mohamed
Life Sciences (2021) Vol. 275, pp. 119387-119387
Closed Access | Times Cited: 23
The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence
Lucas M. Kangussu, Lucas Alexandre Santos Marzano, Cássio Ferraz Souza, et al.
Protein and Peptide Letters (2019) Vol. 27, Iss. 6, pp. 463-475
Closed Access | Times Cited: 26
Brain bioenergetics in chronic hypertension: Risk factor for acute ischemic stroke
Federica Ferrari, R. F. Villa
Biochemical Pharmacology (2022) Vol. 205, pp. 115260-115260
Closed Access | Times Cited: 13
The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19
Jingwen Li, Xiangrui Kong, Tingting Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9960-9960
Open Access | Times Cited: 2
The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential
Aisling McFall, Stuart A. Nicklin, Lorraine M. Work
Cellular Signalling (2020) Vol. 76, pp. 109809-109809
Open Access | Times Cited: 18
Neuroprotection in Stroke—Focus on the Renin-Angiotensin System: A Systematic Review
Sebastian Andone, Zoltán Bajkó, Anca Moțățăianu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3876-3876
Open Access | Times Cited: 10
Involvement of angiotensin-(1–7) in the neuroprotection of captopril against focal cerebral ischemia
Meng-Xing Tao, Xue Xiao, Li Gao, et al.
Neuroscience Letters (2018) Vol. 687, pp. 16-21
Closed Access | Times Cited: 16
Angiotensin-(1–7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage
Filippo Annoni, Federico Moro, Enrico Caruso, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Transgenic rat with overproduction of ubiquitous angiotensin-(1-7) presents neuroprotection in a model of ischemia and reperfusion
Lucas M. Kangussu, Ana Flávia Almeida-Santos, Lorena F. Fernandes, et al.
Brain Research Bulletin (2022) Vol. 192, pp. 184-191
Open Access | Times Cited: 9
Bisindole compound 4ae ameliorated cognitive impairment in rats with vascular dementia by anti-inflammation effect via microglia cells
Feng Zhang, Ke‐Qing Zhao, Tao Tang, et al.
European Journal of Pharmacology (2021) Vol. 908, pp. 174357-174357
Closed Access | Times Cited: 12
The protective effect of pregabalin and xanthenone on testicular ischemia/reperfusion injury in rats
Maha M. Abdel‐Fattah, Ahmed Ahmed, Rabeh Khairy Saleh, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 6, pp. 1080-1093
Closed Access | Times Cited: 1
Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion
Mariana Moreira Coutinho Arroja, Emma Reid, Lisa A. Roy, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Cyclic angiotensin-(1-7) contributes to rehabilitation of animal performance in a rat model of cerebral stroke
Anneke Kuipers, Gert N. Moll, Aharon Levy, et al.
Peptides (2019) Vol. 123, pp. 170193-170193
Open Access | Times Cited: 10
Skullcapflavone II protects neuronal damage in cerebral ischemic rats via inhibiting NF-ĸB and promoting angiogenesis
Danpeng Zhao, Jinming Ji, Shanshan Li, et al.
Microvascular Research (2022) Vol. 141, pp. 104318-104318
Closed Access | Times Cited: 5
Reduced disease severity following therapeutic treatment with angiotensin 1–7 in a mouse model of multiple sclerosis
Brett T. Lund, Roslynn Stone, Alexander Levy, et al.
Neurobiology of Disease (2019) Vol. 127, pp. 87-100
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top